Literature DB >> 24551441

Risk of malignancy index as an evaluation of preoperative pelvic mass.

Zinatossadat Bouzari1, Shahla Yazdani1, Ziba Shirkhani Kelagar2, Narges Abbaszadeh3.   

Abstract

BACKGROUND: Risk of malignancy index (RMI) is the best method for discriminating benign and malignant pelvic masses. The aim of this study was to determine the RMI for preoperative evaluation of pelvic mass.
METHODS: This study was performed on 182 women with adenexal mass referred to Yahyahnejiad Hospital of Babol University of Medical Sciences in Iran from 2007 to 2009.The sensitivity, specificity, positive (PPV) and negative predictive values (NPV) of menopausal status, ultrasound finding of pelvic mass and level of serum CA-125, separately or combined into the RMI were calculated and compared.
RESULTS: The mean age of patients was 39.9±9.3 years. The RMI with the cut-off point of 265 had a sensitivity of 91.3%, specificity of 96.2 %, PPV of 77.7% and NPV of 98.7% for diagnosis of malignant masses.
CONCLUSION: Risk of malignancy index should be an effective method for evaluating a patient with adnexal masses before operation and a cut-off point of 265 which has a very high sensitivity, specificity and positive and negative predictive values for discriminating malignant and benign pelvic masses.

Entities:  

Keywords:  CA125; Cut-off point; Risk of Malignancy Index (RMI)

Year:  2011        PMID: 24551441      PMCID: PMC3895832     

Source DB:  PubMed          Journal:  Caspian J Intern Med        ISSN: 2008-6164


  21 in total

1.  Comparison of three risk of malignancy indices in evaluation of pelvic masses.

Authors:  A P Manjunath; K Sujatha; R Vani
Journal:  Gynecol Oncol       Date:  2001-05       Impact factor: 5.482

2.  Distinguishing benign and malignant pelvic masses: the value of different diagnostic methods in everyday clinical practice.

Authors:  Mirjam J A Engelen; Alphons H H Bongaerts; Wim J Sluiter; Harm H de Haan; Dick H Bogchelman; Els M Tenvergert; Pax H B Willemse; Ate G J van der Zee
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2006-11-22       Impact factor: 2.435

3.  A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer.

Authors:  I Jacobs; D Oram; J Fairbanks; J Turner; C Frost; J G Grudzinskas
Journal:  Br J Obstet Gynaecol       Date:  1990-10

4.  Comparison of two malignancy risk indices based on serum CA125, ultrasound score and menopausal status in the diagnosis of ovarian masses.

Authors:  G Morgante; A la Marca; A Ditto; V De Leo
Journal:  Br J Obstet Gynaecol       Date:  1999-06

5.  Cancer statistics, 1998.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1998 Jan-Feb       Impact factor: 508.702

6.  The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index.

Authors:  A P Davies; I Jacobs; R Woolas; A Fish; D Oram
Journal:  Br J Obstet Gynaecol       Date:  1993-10

7.  Risk of malignancy index in the preoperative evaluation of pelvic masses.

Authors:  B R Obeidat; Z O Amarin; J A Latimer; R A Crawford
Journal:  Int J Gynaecol Obstet       Date:  2004-06       Impact factor: 3.561

8.  A risk of malignancy index in preoperative diagnosis of ovarian cancer.

Authors:  Shuiqing Ma; Keng Shen; Jinghe Lang
Journal:  Chin Med J (Engl)       Date:  2003-03       Impact factor: 2.628

9.  Risk of malignancy index for adnexal masses.

Authors:  N Akdeniz; U Kuyumcuoğlu; A Kale; M Erdemoğlu; F Caca
Journal:  Eur J Gynaecol Oncol       Date:  2009       Impact factor: 0.196

10.  Risk of malignancy index in the preoperative evaluation of patients with adnexal masses.

Authors:  Erik Soegaard Andersen; Aage Knudsen; Per Rix; Birger Johansen
Journal:  Gynecol Oncol       Date:  2003-07       Impact factor: 5.482

View more
  2 in total

1.  A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass.

Authors:  Santosh Kumar Dora; Atal Bihari Dandapat; Benudhar Pande; Jatindra Prasad Hota
Journal:  J Ovarian Res       Date:  2017-08-14       Impact factor: 4.234

Review 2.  ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors.

Authors:  Dirk Timmerman; François Planchamp; Tom Bourne; Chiara Landolfo; Andreas du Bois; Luis Chiva; David Cibula; Nicole Concin; Daniela Fischerova; Wouter Froyman; Guillermo Gallardo Madueño; Birthe Lemley; Annika Loft; Liliana Mereu; Philippe Morice; Denis Querleu; Antonia Carla Testa; Ignace Vergote; Vincent Vandecaveye; Giovanni Scambia; Christina Fotopoulou
Journal:  Int J Gynecol Cancer       Date:  2021-06-10       Impact factor: 3.437

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.